Document Detail


Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
MedLine Citation:
PMID:  16153758     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The BCG vaccine for tuberculosis has an outstanding safety record, with only occasional reports of adverse reactions. In some countries multiple BCG vaccinations have been given to children, but with no apparent benefit. We show here that in the highly susceptible guinea pig model of Mycobacterium tuberculosis infection animals receiving three sequential injections of BCG began to die unexpectedly at times after aerosol challenge much earlier than animals receiving the vaccine only once. Animals receiving three injections with BCG had extensive, disseminated lesions in the lungs, spleen and liver that were similar to non-vaccinated animals. In these animals there was effacement of the pulmonary, hepatic and splenic architecture by extensive areas of fibrosis with residual granulomatous inflammation and necrosis. This contrasted to the saline control group in which active inflammation was accompanied by extensive areas of necrosis but with less fibrosis in the lungs and spleen. Granulomatous inflammation was less severe and was not complicated by necrosis or extensive fibrosis in animals receiving a single injection with BCG. These data indicate that multiple BCG vaccination, which is akin to super-infection with the living vaccine, leads to major organ failure pathology.
Authors:
Randall J Basaraba; Angelo A Izzo; Lise Brandt; Ian M Orme
Related Documents :
10501638 - 'we shall not find salvation in inoculation': bcg vaccination in scandinavia, britain a...
7727638 - Relationship between bacille calmette-guérin (bcg) strains and the efficacy of bcg vac...
3885848 - Ineffectiveness and toxicity of bcg vaccine for the prevention of recurrent genital her...
9085388 - Bcg vaccination to prevent tuberculosis in health care workers: a decision analysis.
7795768 - Mumps outbreak in a highly vaccinated school population. evidence for large-scale vacci...
19870078 - Studies on typhus fever : ix. on the serum reactions of mexican and european typhus ric...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2005-08-24
Journal Detail:
Title:  Vaccine     Volume:  24     ISSN:  0264-410X     ISO Abbreviation:  Vaccine     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-19     Completed Date:  2006-02-27     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  280-6     Citation Subset:  IM    
Affiliation:
Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA. basaraba@colostate.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / adverse effects*
Animals
BCG Vaccine / adverse effects*
Female
Guinea Pigs
Liver / pathology
Lung / pathology
Mycobacterium tuberculosis / immunology*
Spleen / pathology
Survival Analysis
Tuberculosis / immunology*,  mortality*,  pathology
Vaccination / adverse effects
Grant Support
ID/Acronym/Agency:
AI-0400091/AI/NIAID NIH HHS; AI-054697/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/BCG Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against...
Next Document:  Phenotypic assessment of Neisseria meningitidis isolates obtained from patients with invasive mening...